Patients with portal hypertension exhibit peripheral vasodilatation and inadequate intravascular effective volume, which elicit compensatory responses including enhanced sympathetic activity, RAAS activation, and elevated circulating vasopressin and ET-1 levels [39]. Here, EDN1 is linked to liver disorder.